Corvel Corp(CRVL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 4:01 PM ET (Korea 10/28 05:01)
Full metrics table
| Index | RUT | P/E | 36.81 | EPS (ttm) | 2.25 | Insider Own | 38.91% | Shs Outstand | 50.6M | Perf Week | 1.67% |
| Market Cap | 4.18B | Forward P/E | - | EPS next Y | - | Insider Trans | -1.38% | Shs Float | 30.9M | Perf Month | 11.96% |
| Enterprise Value | 3.95B | PEG | - | EPS next Q | - | Inst Own | 55.89% | Short Float | 3.97% | Perf Quarter | 32.8% |
| Income | 0.12B | P/S | 4.25 | EPS this Y | - | Inst Trans | 0.69% | Short Ratio | 6.48 | Perf Half Y | 42.58% |
| Sales | 0.98B | P/B | 10.23 | EPS next 5Y | - | ROA | 17.92% | Short Interest | 1.23M | Perf YTD | 22.17% |
| Book/sh | 8.08 | P/C | 16.32 | EPS past 3/5Y | 19.34% 20.24% | ROE | 30.7% | 52W High | -2.91% ($85.15) | Perf Year | 11.03% |
| Cash/sh | 5.07 | P/FCF | 36.69 | Sales past 3/5Y | 10.08% 11.64% | ROIC | 26.84% | 52W Low | 84.41% ($44.83) | Perf 3Y | 30.31% |
| Dividend Est. | - | EV/EBITDA | 21.45 | EPS Y/Y TTM | 14.95% | Gross Margin | 22.28% | Volatility(W/M) | 2.23% 2.4% | Perf 5Y | 40.13% |
| Dividend TTM | - | EV/Sales | 4.01 | Sales Y/Y TTM | 7.09% | Oper. Margin | 15.37% | ATR (14) | 2.01 | Perf 10Y | 638.79% |
| Dividend Ex-Date | - | Quick Ratio | 1.94 | EPS Q/Q | 20.63% | Profit Margin | 11.72% | RSI (14) | 69.81 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.94 | Sales Q/Q | 10.74% | SMA20 | 4.62% ($79.02) | Beta | 1.08 | Target Price | - |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2026/8/5 | SMA50 | 11.79% ($73.95) | Rel Volume | 0.81 | Prev Close | $84.59 |
| Employees | 5239 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | - | SMA200 | 32.74% ($62.28) | Avg Volume(3M) | 0.19M | Price | $82.67 |
| IPO | 1991/6/28 | Option/Short | Yes/Yes | Trades | 3160 | Volume | 152,445 | Change | -2.27% |
A U.S. insurance services company that provides workers' compensation claims management and care solutions. It offers workers' compensation claims processing, medical cost management, and care management technology solutions to insurance companies and businesses, giving it exposure to claims volume and demand for medical cost management. The company operates in the workers' compensation claims management sector.
Over the past 1 year, on the higher side
3% below its 1-year high.
Traded about as much as usual. That is 81% of its average volume.
CRVL makes money exceptionally well
Of every $100 in sales, $15.37 is kept as operating profit.
Tap to view numbers
However, it looks expensive
Counting its debt, for $100 of yearly operating cash you would pay $2,145. Peers typically go for $1,365. Compared with its own 5-year average, it is 24% cheaper now.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +40.1%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 55.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #10 of 24 in the industry
Based on market cap of $4B.
FAQ
What kind of company is CRVL?
CRVL belongs to the Financial sector and operates in the Insurance Brokers industry.
What is the market cap of CRVL?
The market cap of CRVL is approximately $4.2B, ranking 1,502 within its sector.
What is the P/E ratio of CRVL?
CRVL has a P/E ratio of approximately 36.8x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for CRVL?
CRVL has recorded a 52-week high of $85.15 and a low of $44.83.
